January 28, 2015
This is the unedited version sent to the Orthomolecular News Service. The edited version was "watered-down" .
They’re Back! The Pharmaceutical Shills
By Wendell O. Belfield Jr.
Optidose-Orthomolecular Nutritional Advocate
“It is difficult to get a man to understand something when his job depends on not understanding it.”
The pharmaceutical shill (a person who publicly helps or gives credibility to a person or organization without disclosing that they have a close relationship with the person or organization.) is an odd species of human. When the pharmaceutical shill emerges from their three to six months slumber they have a peculiar habit. Most mammals that emerge from hibernation have an innate need to consume a diet that will optimize their nutrient intake. The pharmaceutical shill has no such instinctive need. Instead, they are in a zombie state for several weeks. While in their zombie state they instinctively begin their ritual assault on vitamin supplements. They proceed to do their research by proclamation rather than pursue a thorough investigation. It is much easier, and they feel nobody will know the difference.
The zombie shills may appear drunk or in a stupor until their bodies get back to some semblance of normality. As their transformation is taking place, Big Pharma’s strangle hold over mainstream media continues. Fortunately, while still in their zombie state, the shills are such poor marksmen (the inability to get to the crux of a problem) they keep on missing the target! Orthomolecular medicine has become use to such assaults. They now look forward to these spurious attacks because they provide a level of comic relief from the tensions of serious Orthomolecular research.
In this year’s rant the pharmaceutical shills published an article titled (24 August 2017), We Should Never Have Told People to Start Taking Vitamins and New Research Linking One Type to Cancer Shows Why. https://www.aol.com/article/news/2017/08/24/we-should-never-have-told-people-to-start-taking-vitamins-and-new-research-linking-one-type-to-cancer-shows-why/23178576/
The gist of the article is the following: Epidemiologists at two American Cancer research institutes (Mayo Clinic and Ohio State University) and the National Taiwan University studied 77,000 men between the ages of 50-76. The research institutes found evidence to suggest that long term (10 years) high dose supplementation with 20 mg of vitamin B6 (Pyridoxine Hydrochloride) and 55 mg of B12 (cobalamin)- two supplements that allegedly increase energy-was linked with an increase in risk(3 times more likely) of developing lung cancer in men who regularly smoked.
What was not made clear during the rant was why vitamins B6 and B12 were chosen for lung cancer research. In the book; “Putting It All Together: The New Orthomolecular Nutrition, written by Abram Hoffer, M.D., Ph.D. & Morton Walker, D.P.M.” These two eminent physicians write, “vitamin B6 should be taken for the protection against arteriosclerosis, heart disease and strokes. Vitamin B6 is one of the nutrients essential in the conversion of homocysteine to the nontoxic cystathionine. Vitamin B12 (cobalamin) is used to maintain the health of all body cells by production of nucleic acid. It maintains nerve tissue sheaths, helps in blood formation and the production of genetic material DNA and RNA and affects protein and fat cells.”
As poor marksmen they missed the fact that the most recent data (2015) from the United States National Poison Data System emphatically states that there were no deaths from supplements, no deaths from minerals or Amino acids, and no deaths from homeopathics or herbs.
The pioneering research conducted by Indu B. Chatterjee PhD will demonstrate how specious the pharmaceutical shill’s argument is.
Dr. Chatterjee was a colleague of Irwin Stone PhD and two timed unshared Nobel Laureate Linus Pauling PhD. This is a direct quote from Chatterjee; “I had indeed significant contact with the late Dr. Irwin Stone and Linus Pauling. In fact, Dr. Irwin Stone sent a copy of his book The Healing Factor: Vitamin C Against Disease with a handwritten inscription in red ink: “In appreciation for your pioneering work on ascorbate biosynthesis", dated 13 March 1974. (This glowing tribute from one of the pioneers of Orthomolecular medicine should have landed Dr. Chatterjee into the Orthomolecular Medicine Hall of Fame. This is a discussion for another time.)
In an e-mail sent to me five years ago it is quite apparent that Dr. Chatterjee was a more skillful marksmen and superior researcher than the epidemiologists at the two American Cancer research institutes and the National Taiwan University.
Dear Wendell O. Belfield, Jr;
Thank you. I shall be glad for the nomination of my name to the Orthomolecular Medicine Hall of Fame.
Besides having the importance of vitamin C in our day to day nutrition, our recent work indicates that vitamin C is really a panacea for preventing cigarette smoke-related fatal diseases like emphysema, cardiovascular disease, and also lung cancer. Although cigarette smoke contains about 4000 compounds, p-benzoquinone produced from p-benzosemiqinone of cigarette smoke in the lungs of smokers appears to be a major factor for producing the diseases.
All commercial cigarettes contain substantial amounts (100-200 micrograms/cigarette smoke) of p-benzosemiquinone, which is oxidized to p-benzoquinone in the lungs of smokers and denatures proteins and DNA. From lungs, p-benzoquinone goes to blood and all organs. Because these dreadful diseases have no cure, prevention should be the target. Vitamin C is a strong antagonist of p-benzoquinone and intake of a moderately large of vitamin C (about 2g/day) by smokers should almost completely prevent cigarette smoke-induced diseases. In support of this, I am appending below some of our recent publications.
I. B. Chatterjee
- Archita Das, Neekkan Dey, Arunava Ghosh, Tanusree Das, Indu B. Chatterjee* NAD(P)H: Quinone Oxidoreductase 1 Deficiency Conjoint with Marginal Vitamin C Deficiency Causes Cigarette Smoke Induced Myelodysplastic Syndromes. PLoS ONE May 2011 | Volume 6 | Issue 5 | e20590
- Neekkan Dey, Dhruba J. Chattopadhyay, and Indu B. Chatterjee* MolecularMechanisms of Cigarette Smoke-Induced Proliferation of Lung Cells and Prevention by Vitamin C. Journal of Oncology,Volume 2011, Article ID 561862, doi:10.1155/2011/561862
- Ghosh A, Choudhury A, Das A, Chatterjee NS, Das T, Chowdhury R, Panda K, Banerjee R, Chatterjee IB*. Cigarette smoke induces p-benzoquinone-albumin adduct in blood serum: Implications on structure and ligand binding properties. Toxicology. 2012 Feb 26;292(2-3):78-89. Epub 2011 Dec 1.
- Archita Das, Neekkan Dey, Arunava Ghosh, Shovanendu Das, Dhruba J Chattopadhyay, Indu B. Chatterjee* Molecular and Cellular Mechanisms of Cigarette Smoke-Induced Myocardial Injury: Prevention by Vitamin C. PLOS ONE September 2012 | Volume 7 | Issue 9 | e44151
- Chatterjee IB. The history of vitamin C research in India. J Biosci. 2009 Jun; 34(2):185-94. No abstract available.
- Banerjee S, Chattopadhyay R, Ghosh A, Koley H, Panda K, Roy
- Definition of a Shill.
- https://en.wikipedia.org/wiki/ShillHoffer, Abram M.D., Walker, Morton, D.P.M Putting It All Together: The New Orthomolecular Nutrition, Keats Publishing, Inc. 1978, pages 112,114
Most Users Ever Online: 288
Currently Browsing this Page:
Guest Posters: 2
Newest Members:Kirsten, Oscar, BlackVault Investigator, alienmint.com, Kristen, Kaila_Kelly-Palencia, Charlotte Beattie, Carole Willis, Teodoro, Meyer72
Administrators: John Greenewald: 393, blackvault: 1777